FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/04/024530 [Registered on: 08/04/2020] Trial Registered Prospectively
Last Modified On: 28/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Management of migraine through Gandharyadi ghrita nasya and Goghrita nasya. A comparative study. 
Scientific Title of Study   A controlled comparative clinical study to evaluate Gandharyadi ghrita nasya and Go ghrita nasya in the management of Ardhavabhedaka w.s.r to Migraine.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Parwati 
Designation  PG scholar 
Affiliation  All India Institute of Ayurveda 
Address  7th floor, Academic block, Dept of Panchakarma.

South West
DELHI
110076
India 
Phone  7503822981  
Fax    
Email  drparwatipingolia@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr SH Acharya 
Designation  DISTINGUISH PROFESSOR 
Affiliation  All India Institute of Ayurveda 
Address  7th floor, Academic block, Department of Panchakarma

South West
DELHI
110076
India 
Phone  9879550157  
Fax    
Email  dracharyadr@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Santosh kumar Bhatted 
Designation  Associate Professor and Head 
Affiliation  All India Institute of Ayurveda 
Address  7th floor, Academic block, Departmrnt of Panchakarma

South West
DELHI
110076
India 
Phone  8851939675  
Fax    
Email  santoshbhatted@rediffmail.com  
 
Source of Monetary or Material Support  
All India institute of Ayurveda, Sarita Vihar, New Delhi 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Santosh Kumar Bhatted  All india institute of Ayurveda  Opd-6, department of panchakarma, All India institute of Ayurveda
South West
DELHI 
8851939675

santoshbhatted@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G||Mental Health,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nasya with Gandharyadi ghrita in the forenoon in the dose of Eight drops in each nostrils for two courses of 7 days each shamana oushadha as Narikela khanda-10gm bid with milk for 15days  for first two day koshtha suddhi will be done by Triphala churna-5gm at bed time. nasya with Gandharyadi ghrita-8drops in each nostrils at afternoon for 7 days. then rest for 7 days. again Nasya with Gandharyadi ghrita-8drops in each nostrils for 7days. Internal medication with Narikela khanda-10gm B.D. with milk for 15 days.  
Comparator Agent  Nasya with suddha Go ghrita in both nostrils in the forenoon with a dosage of Eight drops to each nostrils for 7 days in 2 sitting. shamana oushadha as Narikela khanda  for first two days koshtha suddhi with Triphala churna-5gm at bedtime. Nasya with Goghrita-8drops in each nostrils at afternoon for 7days. then rest for 7 days. Again Nasya with Goghrita-8drops in each nostrils for 7days. Internal medication with Narikela khanda-10gm B.d with milk for 15days. 
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having symptoms of Ardhavabhedaka , 1) Ardha parshwa Shirashoola– unilateral headache
2) Bheda , Toda, Shoola- pulsating , throbbing type of pain
3) Pakshat, Dashahat ,Akasmat- paroxysmal episodes.
4) Prakasha Asahishnata- photophobia, Nausea (Hrillas), vomiting (Chardi).
5) phonophobia 
 
ExclusionCriteria 
Details  Known cases of Secondary headache caused by sinusitis , meningitis , brain tumour, increased intra ocular pressure , malignant HTN.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Response in headache   Assesment will be done on baseline, 23day, 38day and 53day.  
 
Secondary Outcome  
Outcome  TimePoints 
Overall improvement in quality of life.   assesment will be taken on baseline, on 23,38day and 53 day. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/05/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   outcomes will be published after trial in peer reviewed journal for wider dissemination. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Migraine is a  complex  neurological  disorder  that  manifests  with  recurrent headache, nausea, vomiting, photophobia or phonophobia. The prevalence of migraine  is 15% to 20%  in women  and  4% to 7%  in men. In children the prevalence may be as high as 17% and is equal in boys and girls. The highest prevalence  occur between  the  ages of  25yrs and  55 yrs. Based  on  sign  and  symptoms  of  Ardhavabhedaka. It can be  compared  with migraine. Objective of this study is to compare the efficacy of Gandharyadi ghrita nasya and Go ghrita nasya along with internal medication as Narikela khanda in the management of Ardhavabhedaka. Study will conduct in AIIA hospital with taken 15 patients in each groups by block randomization. Diagnosis of patient will be done according Intrernational headache society for migraine. Primary assessment parameter will pain and secondary will quality of life. Total duration of this study will be 53days.


 
Close